Engage with Dr. Jane Aubin, VP Research and Chief Scientific Officer at the Canadian Institutes of Health Research (CIHR) - Feb. 10
The Universities of Waterloo, Wilfrid Laurier and Guelph are pleased to inform the research community about an important opportunity to engage with Dr. Jane Aubin, VP Research and Chief Scientific Officer at the Canadian Institutes of Health Research (CIHR) on Friday February 10th, 2012. Dr. Aubin’s biography appears below.
The event will offer senior academic administrators as well as researchers from health-related disciplines an opportunity to provide feedback on CIHR’s Update from CIHR’s Science Council Regarding Proposed Reforms of Open Programs and Peer Review, http://www.cihr-irsc.gc.ca/e/44566.html.
Representation and feedback from University of Guelph stakeholders will be critical to CIHR’s review of proposed reforms. We hope that you will make every effort to participate in this important discussion.
Associate/Assistant Deans Research are invited to attend a lunch held at the University of Waterloo’s University Club, 12:00-1:30 pm.
All University of Guelph stakeholders (including Associate/Assistant Deans Research)are invited to attend a town-hall meeting held at the University of Waterloo’s Lyle Hallman (South) – room 1621, 2:00-4:00 pm.
Please RSVP at your earliest convenience to Laura Beaupre, Director, Research Support Services, x56616.
A more detailed agenda for the event will be sent to those who RSVP, with directions and parking information.
**************************************************************
Dr. Jane E. Aubin was appointed Chief Scientific Officer (CSO) and Vice-President (VP), Research at CIHR in July 2011. As CSO, Dr. Aubin is responsible for the oversight of all scientific affairs at CIHR and provides CIHR with expert advice on matters relevant to science and technology, potential opportunities and emerging orientations and trends in the national and international health research community. As VP, Research, she is responsible for all aspects of adjudication of grants and awards at CIHR and finally, as a member of the Scientific Council, she participates in the development, implementation, and reporting on CIHR's research and knowledge translation strategy.
Dr. Aubin’s career path has included several senior academic administrative positions, including Chair of the Graduate Department of Dentistry and Director of Postgraduate Dental Education and Chair of the Department of Anatomy and Cell Biology at the University of Toronto. She is currently a member of the Faculty of Medicine at the University of Toronto where she is a Professor of Molecular Genetics and the Director of the Bone Program in the Centre for Modeling Human Disease. Dr. Aubin has been Scientific Director and CEO of the Canadian Arthritis Network of Centres of Excellence and until recently, Scientific Director of CIHR’s Institute of Musculoskeletal Health and Arthritis (IMHA), specializing in arthritis, musculoskeletal, oral and skin conditions.
Dr. Aubin received a B.Sc. (Hons; Chemistry and Mathematics) and the Gold Medal in Chemistry at Queen's University in Kingston. She then completed her Ph.D. in Medical Biophysics at the University of Toronto. She later did her postdoctoral training in Molecular Biology and Biochemistry at the Max Planck Institute for Biophysical Chemistry in Goettingen, Germany.